Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Active as of 2021-11-04 |
{
"resourceType" : "ActivityDefinition",
"id" : "213",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-05T12:52:51.103Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/recommendation-action"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ActivityDefinition 213</b></p><a name=\"213\"> </a><a name=\"hc213\"> </a><a name=\"213-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 7; Last updated: 2023-12-05 12:52:51+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-recommendation-action.html\">RecommendationAction</a></p></div><p><b>url</b>: <a href=\"ActivityDefinition-213.html\">ActivityDefinition IV remdesivir 200 mg then 100 mg/day for 9 days</a></p><p><b>identifier</b>: FEvIR Object Identifier/213, <a href=\"http://terminology.hl7.org/6.1.0/NamingSystem-uri.html\" title=\"As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt \r\n\r\nThis oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: \r\n\r\nNote that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.\r\n\r\nThis OID may also be used in CD.codeSystem.\">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.40.44.11.1</p><p><b>version</b>: 2.0.0-ballot</p><p><b>name</b>: IV_remdesivir_200_mg_then_100_mg_day_for_9_days</p><p><b>title</b>: IV remdesivir 200 mg then 100 mg/day for 9 days</p><p><b>status</b>: Active</p><p><b>date</b>: 2021-11-04 13:34:54+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href=\"http://www.hl7.org/Special/committees/dss\">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: </p><div><p>This example uses the Dosage datatype to represent dosing for IV remdesivir.</p>\n</div><p><b>jurisdiction</b>: <span title=\"Codes:{http://unstats.un.org/unsd/methods/m49/m49.htm 001}\">World</span></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style=\"display: none\">*</td><td>Cite As</td><td><div><p>IV remdesivir 200 mg then 100 mg/day for 9 days [ActivityDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 213. Revised 2021-11-04. Available at: https://fevir.net/resources/ActivityDefinition/213. Computable resource at: https://fevir.net/resources/ActivityDefinition/213.</p>\n</div></td></tr></table><p><b>kind</b>: MedicationRequest</p><p><b>code</b>: <span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 2284960}\">Remdesivir 100 mg Injection</span></p><p><b>intent</b>: Order</p><blockquote><p><b>dosage</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: IV remdesivir 200 mg once on day 1</p><p><b>route</b>: <span title=\"Codes:{http://snomed.info/sct 47625008}\">Intravenous use</span></p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>2</td></tr></table></blockquote><blockquote><p><b>dosage</b></p><p><b>sequence</b>: 2</p><p><b>text</b>: IV remdesivir 100 mg once daily on days 2 through 10</p><p><b>route</b>: <span title=\"Codes:{http://snomed.info/sct 47625008}\">Intravenous use</span></p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>1</td></tr></table></blockquote></div>"
},
"url" : "https://fevir.net/resources/ActivityDefinition/213",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "213",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.40.44.11.1"
}
],
"version" : "2.0.0-ballot",
"name" : "IV_remdesivir_200_mg_then_100_mg_day_for_9_days",
"title" : "IV remdesivir 200 mg then 100 mg/day for 9 days",
"status" : "active",
"date" : "2021-11-04T13:34:54.626Z",
"publisher" : "HL7 International / Clinical Decision Support",
"contact" : [
{
"name" : "HL7 International / Clinical Decision Support",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"description" : "This example uses the Dosage datatype to represent dosing for IV remdesivir.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"author" : [
{
"name" : "Brian S. Alper"
}
],
"relatedArtifact" : [
{
"type" : "cite-as",
"citation" : "IV remdesivir 200 mg then 100 mg/day for 9 days [ActivityDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 213. Revised 2021-11-04. Available at: https://fevir.net/resources/ActivityDefinition/213. Computable resource at: https://fevir.net/resources/ActivityDefinition/213."
}
],
"kind" : "MedicationRequest",
"code" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2284960",
"display" : "Remdesivir 100 mg Injection"
}
]
},
"intent" : "order",
"dosage" : [
{
"sequence" : 1,
"text" : "IV remdesivir 200 mg once on day 1",
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous use"
}
]
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 2
}
}
]
},
{
"sequence" : 2,
"text" : "IV remdesivir 100 mg once daily on days 2 through 10",
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous use"
}
]
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 1
}
}
]
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-11-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change